InMedica: Slovenian Device Incubator Looks To Fill Infrastructure Gap
Executive Summary
One of the major challenges faced by a European medtech start-up community that is already arguably undersized has been a lack of infrastructure. A group of medical device executives are trying to address that problem through the launch of an incubator, InMedica, built upon a network of support services that is integrally connected to the incubator, in effect forming its own medical device cluster in the unlikely setting of Slovenia, a country of two million people in south central Europe.
You may also be interested in...
US FDA Requests Ranitidine Removal But Also Encourages Research For Stable Formulations
FDA requests immediate removal of ranitidine OTC and Rx drugs after third-party testing finds contaminant NDMA increases during storage, especially at higher temperatures. CDER Director Janet Woodcock asks firms to reformulate products to be stable as the ingredient remains approved.
Takeda Gets New India Chief, Mandate To Broaden Access
Takeda appoints new country head for India and aims to improve patient access to innovative medicines in the largely out-of-pocket market.
US FDA Exploring Virtual Advisory Cmtes.; Might Sponsors Want To Wait For In-Person Meetings?
Likelihood of webcast-only advisory committee meetings may depend on the extent of the coronavirus outbreak, Office of New Drugs Director Peter Stein tells the Pink Sheet in an interview.
Need a specific report? 1000+ reports available
Buy Reports